Advertisement

Topics

EF Johnson Technologies, Inc. Company Profile

20:06 EDT 21st June 2018 | BioPortfolio

Headquartered in Irving, Texas, EF Johnson Technologies, Inc. focuses on innovating, developing and marketing the highest quality secure communications solutions to organizations whose mission is to protect and save lives. The Company's customers include first responders in public safety and public service, the federal government, and industrial organizations. The Company's products are marketed under the EFJohnson, 3e Technologies International, and Transcrypt International names and are Made in America. For more information, visit http://www.EFJohnsonTechnologies.com.


News Articles [879 Associated News Articles listed on BioPortfolio]

Johnson & Johnson to buy surgery technologies developer Orthotaxy

Johnson & Johnson Medical Devices, via its French affiliate Apsis, has acquired software-enabled surgery technologies developer Orthotaxy for an undisclosed sum.

Johnson & Johnson verkauft Desinfektionssparte für 2,7 Milliarden Dollar: Johnson & Johnson steigt aus ...

Johnson & Johnson steigt aus dem Geschäft für Sterilisationsprodukte aus: Die Sparte übernimmt der Konzern Fortive für 2,7 Milliarden Dollar.Der Pharma- und Konsumgüterkonzern Johnson & Johnson (...

Earnings In Focus: Jan. 23 (FUL, ATI, JNJ, PG, VZ)

NEW BRUNSWICK (dpa-AFX) - Allegheny Technologies Inc. (ATI), H.B. Fuller Co. (FUL), Johnson & Johnson (JNJ), The Procter & Gamble Co. (PG), and Verizon Communications Inc. (VZ) are among few notab...

$20.21 Billion in Sales Expected for Johnson & Johnson (JNJ) This Quarter

Brokerages forecast that Johnson & Johnson will report $20.21 billion in sales for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Johnson & Joh...

Johnson & Johnson falls on report that lawsuits could expose damaging documents

Johnson & Johnson has been ordered to pay $55 million to a woman who claims its talcum powder caused her ovarian cancer, the second such judgment against the manufacturer in three months. Johnson&...

After rebates, Johnson & Johnson says prices fell 4.6% last year

In a report highlighting the company’s record on corporate responsibility, Johnson & Johnson notes…

Change of CFO at Johnson & Johnson

After 19 years with the US healthcare giant Johnson & Johnson (NYSE: JNJ), Dominic Caruso, executive…

Johnson & Johnson erhält Kaufgebot für Blutzuckergeschäft

Von Cara Lombardo NEW YORK (Dow Jones)--Johnson & Johnson hat ein Übernahmegebot für sein Geschäft mit Geräten für die Kontrolle des Blutzuckerspiegels erhalten. Die Beteiligungsgesellschaft Plat...

PubMed Articles [390 Associated PubMed Articles listed on BioPortfolio]

Nursing care of a boy seriously infected with Steven-Johnson syndrome after treatment with azithromycin: A case report and literature review.

Stevens-Johnson syndrome (SJS) is an acute blistering disease of the skin and mucous membranes. SJS in children is not common but potentially serious disease. But the epidemiology of SJS in China is n...

Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening cutaneous reactions, typically to drugs or infection. The incidence and outcomes of these conditions in childre...

Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015).

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are serious mucocutaneous reactions. In Spain, the epidemiology and resulting expenses of these diseases are not well established.

Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals.

Adverse drug reactions are harmful and involuntary responses to drugs that occur at doses normally used for a given condition. Among them are Stevens-Johnson syndrome and toxic epidermal necrolysis, b...

Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of chikungunya fever: A case series.

Chikungunya fever is a benign, self-limiting, acute viral illness. An epidemic occurred in New Delhi, India, in August and September 2016. We observed many cases with atypical cutaneous features mimic...

Clinical Trials [443 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Companies [1417 Associated Companies listed on BioPortfolio]

Johnson and Johnson

Johnson & Johnson, employing approximately 119,000 people worldwide, is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnso...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson (China) Investment Co., Ltd. is a foreign investment entity established in China by Johnson & Johnson in 1998. For more information about Johnson & Johnson and its operating unit...

JOHNSON'S(R) Brand

JOHNSON'S® Brand from Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc., has a long tradition of providing pure, mild, gentle and clinically-proven p...

JANSSEN-ORTHO INC

Since 1961 Janssen-Cilag has been a member of the Johnson & Johnson family of companies. Founded in 1886, Johnson & Johnson today is the world's most comprehensive manufacturer of healthcare products ...

More Information about "EF Johnson Technologies, Inc." on BioPortfolio

We have published hundreds of EF Johnson Technologies, Inc. news stories on BioPortfolio along with dozens of EF Johnson Technologies, Inc. Clinical Trials and PubMed Articles about EF Johnson Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EF Johnson Technologies, Inc. Companies in our database. You can also find out about relevant EF Johnson Technologies, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record